EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Singular Health Group's Enterprise Value is A$60.29 Mil.
Singular Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.35 Mil. Therefore, Singular Health Group's EV-to-FCF for today is -13.87.
The historical rank and industry rank for Singular Health Group's EV-to-FCF or its related term are showing as below:
ASX:SHG'
s EV-to-FCF Range Over the Past 10 Years
Min: -30.74 Med: -5.74 Max: -1.05
Current: -11.2
During the past 5 years, the highest EV-to-FCF of Singular Health Group was -1.05. The lowest was -30.74. And the median was -5.74.
ASX:SHG's EV-to-FCF is ranked worse than 100% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 17.51
vs ASX:SHG: -11.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Singular Health Group (ASX:SHG) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Singular Health Group's PE Ratio (TTM) for today is calculated as:
Singular Health Group's share price for today is A$0.22.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Singular Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.025.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Singular Health Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singular Health Group EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Singular Health Group's EV-to-FCF falls into.
Singular Health Group's current Enterprise Value is A$60.29 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Singular Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Health Group (ASX:SHG) has a EV-to-FCF of -13.87 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Singular Health Group and its competitors. According to the industry distribution chart, Singular Health Group ranks #999999 out of 407 companies in the Healthcare Providers & Services industry.
Is Singular Health Group's EV-to-FCF too high?
Singular Health Group's current EV-to-FCF is -13.87. Based on the distribution chart, Singular Health Group ranks #999999 out of 407 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Singular Health Group has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Singular Health Group ranks #999999 out of 407 companies for EV-to-FCF. This places Singular Health Group in the lower half of its industry. The industry median EV-to-FCF is 17.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.51, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Singular Health Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singular Health Group's current EV-to-FCF is -13.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.22 — trading 100% above its estimated fair value. The current EV-to-FCF is -13.87. Singular Health Group's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current EV-to-FCF is -13.87 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Singular Health Group (ASX:SHG) Overvalued in 2026?
Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued.
The current stock price of A$0.22 is trading 100% above its estimated GF Value™ of A$0.11.
GuruFocus considers Singular Health Group to be Significantly Overvalued.
Key valuation signals for ASX:SHG:
EV-to-FCF: -13.87
GF Value™: A$0.11 vs. price of A$0.22 (100% above fair value)
No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score
Get the complete analysis for ASX:SHG
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SHG has been successfully added to your 
